ATE458813T1 - Verfahren zur bestimmung von ctp11 sowie zur bestimmung des metastatischen potentials einer tumor probe - Google Patents

Verfahren zur bestimmung von ctp11 sowie zur bestimmung des metastatischen potentials einer tumor probe

Info

Publication number
ATE458813T1
ATE458813T1 AT00124240T AT00124240T ATE458813T1 AT E458813 T1 ATE458813 T1 AT E458813T1 AT 00124240 T AT00124240 T AT 00124240T AT 00124240 T AT00124240 T AT 00124240T AT E458813 T1 ATE458813 T1 AT E458813T1
Authority
AT
Austria
Prior art keywords
determining
ctp11
tumor sample
metastatic potential
metastatic
Prior art date
Application number
AT00124240T
Other languages
English (en)
Inventor
Muijen Goosen Van
Albert Zendman
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE458813T1 publication Critical patent/ATE458813T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT00124240T 1999-11-11 2000-11-10 Verfahren zur bestimmung von ctp11 sowie zur bestimmung des metastatischen potentials einer tumor probe ATE458813T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99122454 1999-11-11

Publications (1)

Publication Number Publication Date
ATE458813T1 true ATE458813T1 (de) 2010-03-15

Family

ID=8239370

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00124240T ATE458813T1 (de) 1999-11-11 2000-11-10 Verfahren zur bestimmung von ctp11 sowie zur bestimmung des metastatischen potentials einer tumor probe

Country Status (7)

Country Link
US (1) US6677118B1 (de)
JP (1) JP3561229B2 (de)
AT (1) ATE458813T1 (de)
AU (1) AU749907B2 (de)
CA (1) CA2322713C (de)
DE (1) DE60043877D1 (de)
ES (1) ES2339322T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015111209A1 (ja) * 2014-01-27 2015-07-30 株式会社日立製作所 核酸増幅反応後の反応液の解析方法、解析装置及び核酸増幅反応後の反応液処理装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861248A (en) 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
DE19811193A1 (de) 1998-03-10 1999-09-16 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Prostatatumorgewebe

Also Published As

Publication number Publication date
CA2322713C (en) 2009-02-24
ES2339322T3 (es) 2010-05-19
AU749907B2 (en) 2002-07-04
CA2322713A1 (en) 2001-05-11
JP2001190286A (ja) 2001-07-17
AU6669800A (en) 2001-05-17
US6677118B1 (en) 2004-01-13
DE60043877D1 (de) 2010-04-08
JP3561229B2 (ja) 2004-09-02

Similar Documents

Publication Publication Date Title
DE69714630D1 (de) Biosensor und Verfahren zur quantitaven Analyse von biochemischen Substraten
DE69735295D1 (de) Verfahren zur Aufkonzentrierung von Antikörperlösungen
DE69737258D1 (de) Verfahren und Vorrichtung zur Detektion von akutem myokardischem Infarkt
DE69928683D1 (de) Verfahren zur amplifikation und zur sequenzierung von nukleinsäuren
DE60032226D1 (de) Verfahren zur induktion von krebszellentod und tumorregression
DE69728017D1 (de) Vorrichtungen und Verfahren zur Erkennung von mehreren Analyten in Proben
DE59708311D1 (de) Volumenunabhängiger diagnostischer Testträger und Verfahren zur Bestimmung von Analyten mit dessen Hilfe
DE69839967D1 (de) Verfahren zur gleichzeitigen entzerrung und erkennung von vielfachbenutzersignalen
DE69719057D1 (de) Verfahren zur signalverstärkung
DE69811310D1 (de) Verfahren und Vorrichtung zur Detektion und Endpunkt-Detektion von Vordergrund-Sprachsignalen
DE3584496D1 (de) Verfahren zur aufsaugung und festhaltung von harn.
DE69619611D1 (de) Verfahren und Vorrichtung zur Bestimmung der petrologischen Eigenschaften von Schichtgesteinen
DE69605330D1 (de) Vorrichtung zur Induktions-Bohrlochmessung in Gegenwart von metallischen Wänden
DE69524161D1 (de) Verfahren zur Bestimmung von Fibrinogen und Reagenz zu dessen Bestimmung
DE69704328D1 (de) Verfahren zur quantitativen Bestimmung von 1,5-Anhydroglucitol, sowie Reagenz zur quantitativen Bestimmung
DE69717001D1 (de) Verfahren zur Bestimmung des Endpunktes von enzymatischen Nachweisverfahren
DE69937678D1 (de) Verfahren zur schnellen bestimmung von bakterien
DE59712415D1 (de) Verfahren zur amplifikation von nukleinsäure
DE69934789D1 (de) Verfahren zur bestimmung der antibiotikasensitivität von bakterien
DE60138164D1 (de) Verfahren zur elektrochemischen Bearbeitung von Kanälen
DE69627990D1 (de) Verfahren zur Erkennung der Versprödung von rostfreiem Duplexstahl
DE3585238D1 (de) Verfahren zur bestimmung des reduzierten zustands von nicotinamid-adenin-dinukleotid.
DE59806380D1 (de) Verfahren zur Abstandsmessung und Durchführung des Verfahrens
ATE458813T1 (de) Verfahren zur bestimmung von ctp11 sowie zur bestimmung des metastatischen potentials einer tumor probe
DE69927265D1 (de) Verfahren und testsatz zur frühdiagnose von krebs

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1099757

Country of ref document: EP